ArticlebioRxiv : the preprint server for biology2024

Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients.

Insha Zahoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.